Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Plants are constantly exposed to a wide array of biotic and abiotic stresses in their natural environments, posing ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032 ...

Fragments of DNA from long-extinct human relatives still circulate in modern genomes, and in some cases they do more than linger. They actively shape how people survive in extreme environments. The ...

Society / One key revelation in the wide correspondence of the late pedophile: the rich and powerful just aren’t all that ...

Infleqtion has been selected to advance to Phase 3 of the Q4Bio Challenge, a global program demonstrating quantum-enabled solutions for human health.

AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety and reducing waste in production.